Skip to main content
SpringerLink
Log in

Tumorartige Lymphadenopathien

  • Chapter
  • First Online:
Pathologie

  • 3625 Accesses

Zusammenfassung

Die in diesem Kapitel besprochenen Entitäten treten klinisch als lokalisierte Tumoren in Erscheinung. Sie besitzen histologische Eigenschaften reaktiver und gleichermaßen neoplastischer Erkrankungen. Basierend auf dem international akzeptierten Konzept der Nicht-Existenz gutartiger Lymphome werden diese ätiologisch meist unklaren gutartigen oder protrahiert verlaufenden Lymphadenopathien zusammengefasst und detailliert besprochen. Im Einzelnen zählen hierzu die pathologische follikuläre Hyperplasie, das angio-myomatöse Hamartom des Lymphknotens, die verschiedenen Formen und Verläufe des M. Castleman, des M. Kimura und der inflammatorische Pseudotumor des Lymphknotens.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 389.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Hardcover Book
USD 499.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Literatur

  1. Allen PW, Hoffman GJ (1993) Fat in angiomyomatous hamartoma of lymph node. Am J Surg Pathol 17:748–749

    Article  CAS  PubMed  Google Scholar 

  2. Catania VD, Manzoni C, Novello M, Lauriola L, Coli A (2012) Unusual presentation of angiomyomatous hamartoma in an eight-month-old infant: case report and literature review. BMC Pediatr 12:172

    Article  PubMed Central  PubMed  Google Scholar 

  3. Cesarman E (2014) Gammaherpesviruses and lymphoproliferative disorders. Annu Rev Pathol 9:349–372

    Article  CAS  PubMed  Google Scholar 

  4. Chadburn A, Hyjek EM, Tam W, Liu Y, Rengifo T, Cesarman E, Knowles DM (2008) Immunophenotypic analysis of the Kaposi sarcoma herpesvirus (KSHV; HHV-8)-infected B cells in HIV+ multicentric Castleman disease (MCD). Histopathology 53:513–524

    Article  CAS  PubMed  Google Scholar 

  5. Chan AC, Chan KW, Chan JK, Au WY, Ho WK, Ng WM (2001) Development of follicular dendritic cell sarcoma in hyaline-vascular Castleman’s disease of the nasopharynx: tracing its evolution by sequential biopsies. Histopathology 38:510–518

    Article  CAS  PubMed  Google Scholar 

  6. Chan JK, Frizzera G, Fletcher CD, Rosai J (1992) Primary vascular tumors of lymph nodes other than Kaposi’s sarcoma. Analysis of 39 cases and delineation of two new entities. Am J Surg Pathol 16:335–350

    Article  CAS  PubMed  Google Scholar 

  7. Cronin DM, Warnke RA (2009) Castleman disease: an update on classification and the spectrum of associated lesions. Adv Anat Pathol 16:236–246

    Article  PubMed  Google Scholar 

  8. Dargent JL, Lespagnard L, Verdebout JM, Bourgeois P, Munck D (2004) Glomeruloid microvascular proliferation in angiomyomatous hamartoma of the lymph node. Virchows Arch 445:320–322

    Article  PubMed  Google Scholar 

  9. Dispenzieri A (2014) POEMS syndrome: 2014 update on diagnosis, risk-stratification, and management. Am J Hematol 89:214–223

    Article  PubMed  Google Scholar 

  10. Du MQ, Liu H, Diss TC, Ye H, Hamoudi RA, Dupin N, Meignin V, Oksenhendler E, Boshoff C, Isaacson PG (2001) Kaposi sarcoma-associated herpesvirus infects monotypic (IgM lambda) but polyclonal naive B cells in Castleman disease and associated lymphoproliferative disorders. Blood 97:2130–2136

    Article  CAS  PubMed  Google Scholar 

  11. Fajgenbaum DC, van Rhee F, Nabel CS (2014) HHV-8-negative, idiopathic multicentric Castleman disease: novel insights into biology, pathogenesis, and therapy. Blood 123:2924–2933

    Article  CAS  PubMed  Google Scholar 

  12. Falchi L, Capello D, Palumbo B, Rauco A, Emili R, Cianciulli M, Pace R, Capparella V, Liberati F, Liberati AM (2007) A case of nodular sclerosis Hodgkin’s lymphoma repeatedly relapsing in the context of composite plasma cell-hyaline vascular Castleman’s disease: successful response to rituximab and radiotherapy. Eur J Haematol 79:455–461

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  13. Farhi DC, McGuire PW, Luckey CN (1993) Monoclonality in reactive lymphadenopathy: gene rearrangement and multiparameter analysis. Hematol Pathol 7:143–152

    CAS  PubMed  Google Scholar 

  14. Iwaki N, Fajgenbaum DC, Nabel CS, Gion Y, Kondo E, Kawano M, Masunari T, Yoshida I, Moro H, Nikkuni K, Takai K, Matsue K, Kurosawa M, Hagihara M, Saito A, Okamoto M, Yokota K, Hiraiwa S, Nakamura N, Nakao S, Yoshino T, Sato Y (2016) Clinicopathologic analysis of TAFRO syndrome demonstrates a distinct subtype of HHV-8-negative multicentric Castleman disease. Am J Hematol 91:220–226

    Article  CAS  PubMed  Google Scholar 

  15. Katano H, Kaneko K, Shimizu S, Saito T, Irie T, Mori S (1997) Follicular dendritic cell sarcoma complicated by hyaline-vascular type Castleman’s disease in a schizophrenic patient. Pathol Int 47:703–706

    Article  CAS  PubMed  Google Scholar 

  16. Kawabata H, Takai K, Kojima M, Nakamura N, Aoki S, Nakamura S, Kinoshita T, Masaki Y (2013) Castleman-Kojima disease (TAFRO syndrome): a novel systemic inflammatory disease characterized by a constellation of symptoms, namely, thrombocytopenia, ascites (anasarca), microcytic anemia, myelofibrosis, renal dysfunction, and organomegaly : a status report and summary of Fukushima (6 June, 2012) and Nagoya meetings (22 September, 2012). J Clin Exp Hematop 53:57–61

    Article  PubMed  Google Scholar 

  17. Kojima M, Nakamura S, Itoh H, Shimizu K, Murayama K, Iijima M, Hosomura Y, Ohno Y, Yoshida K, Motoori T, Sakata N, Masawa N (2005) Clinical implication of florid reactive follicular hyperplasia in Japanese patients 60 years or older: a study of 46 cases. Int J Surg Pathol 13:175–180

    Article  PubMed  Google Scholar 

  18. Kottler D, Barete S, Quereux G, Ingen-Housz-Oro S, Fraitag S, Ortonne N, Deschamps L, Rybojad M, Flageul B, Crickx B, Janin A, Bagot M, Battistella M (2015) Retrospective multicentric study of 25 Kimura disease patients: emphasis on therapeutics and shared features with cutaneous IgG4-related disease. Dermatology 231:367–377

    Article  CAS  PubMed  Google Scholar 

  19. Laeng RH, Hotz MA, Borisch B (1996) Angiomyomatous hamartoma of a cervical lymph node combined with haemangiomatoids and vascular transformation of sinuses. Histopathology 29:80–84

    CAS  PubMed  Google Scholar 

  20. Nag VK, Nandan D, Bhardwaj M (2015) Kimura’s disease presenting with inguinal lymphadenopathy in an 11-year old girl: a case report. Trop Doct 45:54–56

    Article  PubMed  Google Scholar 

  21. Nguyen DT, Diamond LW, Hansmann ML, Alavaikko MJ, Schroder H, Fellbaum C, Fischer R (1994) Castleman’s disease. Differences in follicular dendritic network in the hyaline vascular and plasma cell variants. Histopathology 24:437–443

    Article  CAS  PubMed  Google Scholar 

  22. Ohgami RS, Zhao S, Ohgami JK, Leavitt MO, Zehnder JL, West RB, Arber DA, Natkunam Y, Warnke RA (2012) TdT+ T-lymphoblastic populations are increased in Castleman disease, in Castleman disease in association with follicular dendritic cell tumors, and in angioimmunoblastic T-cell lymphoma. Am J Surg Pathol 36:1619–1628

    Article  PubMed  Google Scholar 

  23. Pauwels P, Dal Cin P, Vlasveld LT, Aleva RM, van Erp WF, Jones D (2000) A chromosomal abnormality in hyaline vascular Castleman’s disease: evidence for clonal proliferation of dysplastic stromal cells. Am J Surg Pathol 24:882–888

    Article  CAS  PubMed  Google Scholar 

  24. Quintanilla-Martinez L, Sander B, Chan JK, Xerri L, Ott G, Campo E, Swerdlow SH (2016) Indolent lymphomas in the pediatric population: follicular lymphoma, IRF4/MUM1+ lymphoma, nodal marginal zone lymphoma and chronic lymphocytic leukemia. Virchows Arch 468:141–157

    Article  CAS  PubMed  Google Scholar 

  25. Reichard KK, Robinett S, Foucar MK (2011) Clonal cytogenetic abnormalities in the plasma cell variant of Castleman disease. Cancer Genet 204:323–327

    Article  CAS  PubMed  Google Scholar 

  26. Ruco LP, Gearing AJ, Pigott R, Pomponi D, Burgio VL, Cafolla A, Baiocchini A, Baroni CD (1991) Expression of ICAM-1, VCAM-1 and ELAM-1 in angiofollicular lymph node hyperplasia (Castleman’s disease): evidence for dysplasia of follicular dendritic reticulum cells. Histopathology 19:523–528

    Article  CAS  PubMed  Google Scholar 

  27. Talat N, Schulte KM (2011) Castleman’s disease: systematic analysis of 416 patients from the literature. Oncologist 16:1316–1324

    Article  PubMed Central  PubMed  Google Scholar 

  28. Zanetto U, Pagani FP, Perez C (2006) Interfollicular Hodgkin’s lymphoma and Castleman’s disease. Histopathology 48:317–319

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Pathologisches Institut der Universität Würzburg, Würzburg, Deutschland

    Prof. Dr. Dr. h.c. Hans Konrad Müller-Hermelink

  2. Städt. Klinikum Karlsruhe, Karlsruhe, Deutschland

    Prof. Dr. Thomas Rüdiger

Authors
  1. Prof. Dr. Thomas Rüdiger
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Hans Konrad Müller-Hermelink .

Editor information

Editors and Affiliations

  1. der Universität Würzburg, Pathologisches Institut der Universität Würzburg, Würzburg, Bayern, Germany

    Hans Konrad Müller-Hermelink

  2. Medizinische Hochschule Hannover (MHH) Inst. Pathologie, Hannover, Germany

    Hans H. Kreipe

Rights and permissions

Reprints and permissions

Copyright information

© 2019 Springer-Verlag GmbH Deutschland, ein Teil von Springer Nature

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Müller-Hermelink, H.K., Rüdiger, T. (2019). Tumorartige Lymphadenopathien. In: Müller-Hermelink, H., Kreipe, H. (eds) Pathologie. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-540-85184-4_19

Download citation

  • DOI: https://doi.org/10.1007/978-3-540-85184-4_19

  • Published:

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-540-85183-7

  • Online ISBN: 978-3-540-85184-4

  • eBook Packages: Medicine (German Language)

Publish with us

Policies and ethics

Search

Navigation